To date there is no accepted therapy approach for enterococcal infections caused by strains resistant to penicillin, aminoglycosides, and glycopeptides. Quinupristin-dalfopristin is a streptpgramin recently licensed for treatment of vancomycin resistant enterococci. It acts by binding to the bacterial ribosomes and inhibiting protein synthesis. This article presents a patient with hip osteoarthritis caused by multi-resistant, vancomycin resistant E. faecium successfully treated with quinupristin/dalfopristin.
Quinopristin/dalfopristin for the treatment of vancomycin resistant Enterococcus faecium osteo-arthritis following Staphylococcus aureus hip prosthesis infection: case report.
PASTICCI, Maria Bruna;BALDELLI, Franco;MALINCARNE, LISA;MANCINI, Giovanni Battista;MORONI, STEFANO;STAGNI, Giuliano
2005
Abstract
To date there is no accepted therapy approach for enterococcal infections caused by strains resistant to penicillin, aminoglycosides, and glycopeptides. Quinupristin-dalfopristin is a streptpgramin recently licensed for treatment of vancomycin resistant enterococci. It acts by binding to the bacterial ribosomes and inhibiting protein synthesis. This article presents a patient with hip osteoarthritis caused by multi-resistant, vancomycin resistant E. faecium successfully treated with quinupristin/dalfopristin.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
